Omalizumab Therapy for Bronchial Asthma (AB), NSAID Intolerance and Mast Cell Activation (MCAS) led to reproducible heavy vaginal Bleeding in a Patient with systemic Lupus erythematosus (SLE) and Endometriosis

Rossmeissl A, Hotfiel K, Klimek L, Hildebrandt T, Kremenevskiy I, Finzel S, Dostmann L, Raithel M (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Internist Springer Verlag (Germany)

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S39-S40

Conference Proceedings Title: INTERNIST

Involved external institutions

Waldkrankenhaus St Marien DE Germany (DE) Universitätsklinikum Freiburg DE Germany (DE) Verein zur Förderung der Allergie- und Endoskopieforschung am Menschen e.V. (VAEM) DE Germany (DE)

How to cite

APA:

Rossmeissl, A., Hotfiel, K., Klimek, L., Hildebrandt, T., Kremenevskiy, I., Finzel, S.,... Raithel, M. (2020). Omalizumab Therapy for Bronchial Asthma (AB), NSAID Intolerance and Mast Cell Activation (MCAS) led to reproducible heavy vaginal Bleeding in a Patient with systemic Lupus erythematosus (SLE) and Endometriosis. In INTERNIST (pp. S39-S40). HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Rossmeissl, Anja, et al. "Omalizumab Therapy for Bronchial Asthma (AB), NSAID Intolerance and Mast Cell Activation (MCAS) led to reproducible heavy vaginal Bleeding in a Patient with systemic Lupus erythematosus (SLE) and Endometriosis." Proceedings of the INTERNIST HEIDELBERG: SPRINGER HEIDELBERG, 2020. S39-S40.

BibTeX: Download